A Noninvasive Comparison Study between Human Gliomas with IDH1 and IDH2 Mutations by MR Spectroscopy

A Noninvasive Comparison Study between Human Gliomas with IDH1 and IDH2 Mutations by MR Spectroscopy

The oncogenes that are expressed in gliomas reprogram particular pathways of glucose, amino acids, and fatty acid metabolism. Mutations in isocitrate dehydrogenase genes (IDH1/2) in diffuse gliomas are associated with abnormally high levels of 2-hydroxyglutarate (2-HG) levels. The aim of this study...

Full description

Bibliographic Details
Main Authors:	Xin Shen, Natalie L. Voets, Sarah J. Larkin, Nick de Pennington, Puneet Plaha, Richard Stacey, James S. O. McCullagh, Christopher J. Schofield, Stuart Clare, Peter Jezzard, Tom Cadoux-Hudson, Olaf Ansorge, Uzay E. Emir
Format:	Article
Language:	English
Published:	MDPI AG 2019-02-01
Series:	Metabolites
Subjects:	glioma isocitrate dehydrogenase MR spectroscopy metabolism neurochemical profile
Online Access:	https://www.mdpi.com/2218-1989/9/2/35

Similar Items

A noninvasive comparison study between human gliomas with IDH1 and IDH2 mutations by MR spectroscopy
by: Shen, X, et al.
Published: (2019)

Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
by: Emir, U, et al.
Published: (2015)

Research progress of IDH1 and IDH2 mutations in gliomas
by: Shan-shan ZHANG, et al.
Published: (2015-11-01)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01)

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
by: Ali S. Haider, et al.
Published: (2023-04-01)

Mutant IDH in Gliomas: Role in Cancer and Treatment Options
by: Georgios Solomou, et al.
Published: (2023-05-01)

Expression of IDH1, ATRX, p53 in Diagnosis of Gliomas as Per 2016 WHO Classification
by: Lokesh Kumar, et al.
Published: (2023-07-01)

SLIPMAT: A pipeline for extracting tissue-specific spectral profiles from 1H MR spectroscopic imaging data
by: Olivia Vella, et al.
Published: (2023-08-01)

The role of IDH1/2 mutations in the pathogenesis of secondary glioblastomas
by: Eduardo Cambruzzi
Published: (2017-10-01)

Promoter methylation analysis of IDH genes in human gliomas
by: Simon eFlanagan, et al.
Published: (2012-12-01)

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics
by: Ningfang Du, et al.
Published: (2022-05-01)

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET
by: Feng-Min Liu, et al.
Published: (2021-01-01)

The value of multiparametric MRI radiomics in predicting IDH genotype in glioma before surgery
by: Yuanzi Liang, et al.
Published: (2023-11-01)

Beyond the Influence of <i>IDH</i> Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
by: Sanne Venneker, et al.
Published: (2020-11-01)

Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
by: Makoto Nakagawa, et al.
Published: (2022-06-01)

Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report
by: Haiyan Lv, et al.
Published: (2022-06-01)

The Landscape of the Anti-Kinase Activity of the IDH1 Inhibitors
by: Katarzyna Malarz, et al.
Published: (2020-02-01)

Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
by: Santosh Sharma, et al.
Published: (2023-08-01)

<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
by: Seon-Jin Yoon, et al.
Published: (2020-12-01)

Efficacy of Personalized Postoperative Epilepsy Management in Patients with Glioblastoma Utilizing IDH1 Gene Assessment
by: Meng GQ, et al.
Published: (2024-04-01)

Recent advances of IDH1 mutant inhibitor in cancer therapy
by: Wangqi Tian, et al.
Published: (2022-08-01)

Raman Spectroscopy and Machine Learning for IDH Genotyping of Unprocessed Glioma Biopsies
by: Tommaso Sciortino, et al.
Published: (2021-08-01)

Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry
by: Ilkka Haapala, et al.
Published: (2022-05-01)

Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
by: Andreas Stadlbauer, et al.
Published: (2021-04-01)

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
by: Seyyed Ali Hosseini, et al.
Published: (2023-02-01)

Combination of the Distance From Tumor Edge to Subventricular Zone and IDH Mutation Predicts Prognosis of Patients With Glioma
by: Shuixian Zhang, et al.
Published: (2021-08-01)

A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with <i>IDH1</i>-Mutated Solid Tumors
by: Mohammed Khurshed, et al.
Published: (2021-05-01)

A Nomogram Modeling 11C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
by: Weiyan Zhou, et al.
Published: (2020-07-01)

Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
by: Kang H, et al.
Published: (2020-10-01)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
by: Yu-Zhou Chang, et al.
Published: (2020-10-01)

Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta‐analysis
by: Huy Gia Vuong, et al.
Published: (2021-07-01)

Clinical characteristics and MRI features of IDH⁃mutant in insular glioma
by: ZHANG Zi⁃feng, et al.
Published: (2022-05-01)

<i>IDH</i> Mutations in Chondrosarcoma: Case Closed or Not?
by: Sanne Venneker, et al.
Published: (2023-07-01)

Heterogeneity matching and IDH prediction in adult-type diffuse gliomas: a DKI-based habitat analysis
by: Yanhao Liu, et al.
Published: (2023-11-01)

Magnetic resonance spectroscopy for 2-hydroxyglutarate identifies IDH mutant gliomas
by: Larkin, S, et al.
Published: (2013)

Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01)

A comparison of 2-hydroxyglutarate detection at 3 T and 7 T with long-TE semi-LASER
by: Berrington, A, et al.
Published: (2018)

A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database
by: Amrit L. Pappula, et al.
Published: (2021-08-01)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
by: Felix Neumaier, et al.
Published: (2023-03-01)